Funding & Deals

Isomorphic Labs raises $5B for AI drug discovery

TechCrunch: Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.

What happened

Isomorphic Labs, an AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round led by Greenoaks and Sequoia Capital. The company uses AI simulation models and its Drug Design Engine to help identify where drugs can attach to disease-causing proteins and develop compounds to target those points. The funding will support advancing drug candidates toward clinical trials and expanding into additional types of medicine.

What each outlet adds
  • TechCrunch ↗: The company has achieved positive preclinical results in oncology and immunology, building on DeepMind's AlphaFold protein-folding breakthrough.
  • SiliconANGLE ↗: Multiple pharmaceutical companies are already using the platform for drug discovery programs, and the software skips steps that normally require expensive hardware and complex laboratory procedures.
Why it matters

The funding accelerates Isomorphic Labs' ability to move AI-designed drug candidates into clinical trials. The company's technology could streamline drug discovery by reducing the need for expensive hardware and laboratory procedures traditionally required in pharmaceutical development.

Get smart on it

Isomorphic Labs, an AI drug-discovery platform spun out of DeepMind in 2021, has raised $5 billion in funding to advance its drug candidates toward clinical trials. The company uses AI simulation models to design drugs and has achieved positive preclinical results in oncology and immunology, building on DeepMind's AlphaFold protein-folding breakthrough. The funding was led by Greenoaks and Sequoia Capital, with participation from existing backers including Alphabet's venture divisions, Thrive Capital, and others, and will support continued development of the drug-design engine and expansion into additional types of medicine. This fundraise comes after the company's Series B round of $2.1 billion in May and follows founder and CEO Demis Hassabis moving into a chairman role at DeepMind.

Read next
The biggest AI stories, once a day

One short email a day with the stories that matter. Free. Unsubscribe with one click.

Relevant courses

Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.

Browse AI courses on Maven
Related news
Funding & DealsOpen story →

Amazon and Google will together own nearly 30% of Anthropic after its IPO

Amazon will own just under 15% of Anthropic after the IPO, with the option to go much higher. Google is a close second with holdings of nearly 14%.

Funding & DealsOpen story →

Genesis AI Raises $500M At $3.5B Valuation To Bring Its Robots To Factories And Warehouses

Genesis AI, a startup teaching robots to perform physical tasks by learning from human movements, announced Tuesday it has raised $500 million in Series A funding at a $3.5 billion valuation. Premji Invest, Khosla Ventures and Eclipse co-led the round, which brings the company’s disclosed funding to $605 million since its 2024 inception. Genesis previously raised $105 million in a round announced in July 2025. The company is developing both robots and the AI software that controls them. Its appr

Funding & DealsOpen story →

Agile Robots raises $500M to increase production capacity

Agile Robots’ Agile ONE humanoid moving between workstations. | Source: Agile Robots Agile Robots has raised $500 million in Series F funding. This brings the company’s valuation to $8.5 billion and total funding raised to $2 billion. Agile Robots builds and deploys a range of robots, including humanoids, mobile robots, robotic arms, and robotic hands. It also builds the software and AI models behind these robots. The company’s customers include leaders in the automotive, consu

Funding & DealsOpen story →

Nvidia’s startup stakes ballooned to $65B, but Huang’s exit puts future deals in doubt

The value of Nvidia’s private investments has nearly tripled over the past nine months, fueled by Jensen Huang’s aggressive dealmaking and rising valuations of its existing portfolio companies.

Funding & DealsOpen story →

Mirendil raises $1B in funding to speed up AI model development

Mirendil Inc., a provider of software that speeds up artificial intelligence development, has raised $1 billion in early-stage funding. The startup stated on Thursday that Kleiner Perkins and Clearlake Capital jointly led the Series A investment. They were joined by more than a half-dozen others including Google LLC. Mirendil was launched last year by two […] The post Mirendil raises $1B in funding to speed up AI model development appeared first on SiliconANGLE.

Funding & DealsOpen story →

LanceDB raises $57.5M to accelerate AI model training with multimodal data platform

LanceDB Inc., the developer of database technology designed to speed up artificial intelligence models, today announced it has raised $57.5 million in early-stage funding to bring a multimodal lakehouse to researchers, model builders and platform teams. Bessemer Venture Partners and Innovation Endeavors led the Series B round. Other investors in the round included Theory Ventures, […] The post LanceDB raises $57.5M to accelerate AI model training with multimodal data platform appeared firs